101 related articles for article (PubMed ID: 12175977)
1. A novel model of acetaminophen-induced acute hepatic failure in rabbits.
Rahman TM; Selden AC; Hodgson HJ
J Surg Res; 2002 Aug; 106(2):264-72. PubMed ID: 12175977
[TBL] [Abstract][Full Text] [Related]
2. An animal model of fulminant hepatic failure: a feasibility study.
Miller DJ; Hickman R; Fratter R; Terblanche J; Saunders SJ
Gastroenterology; 1976 Jul; 71(1):109-13. PubMed ID: 1278635
[TBL] [Abstract][Full Text] [Related]
3. The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against thioacetamide-induced fulminant hepatic failure.
Bruck R; Aeed H; Shirin H; Matas Z; Zaidel L; Avni Y; Halpern Z
J Hepatol; 1999 Jul; 31(1):27-38. PubMed ID: 10424280
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbits.
Lubek BM; Avaria M; Basu PK; Wells PG
Fundam Appl Toxicol; 1988 May; 10(4):596-606. PubMed ID: 3396787
[TBL] [Abstract][Full Text] [Related]
6. Phenylpropanolamine potentiation of acetaminophen-induced hepatotoxicity: evidence for a glutathione-dependent mechanism.
James RC; Harbison RD; Roberts SM
Toxicol Appl Pharmacol; 1993 Feb; 118(2):159-68. PubMed ID: 8382844
[TBL] [Abstract][Full Text] [Related]
7. Effect of methylxanthines on acetaminophen hepatotoxicity in various induction states.
Kalhorn TF; Lee CA; Slattery JT; Nelson SD
J Pharmacol Exp Ther; 1990 Jan; 252(1):112-6. PubMed ID: 2299585
[TBL] [Abstract][Full Text] [Related]
8. A new hepatic encephalopathy model to monitor the change of neural amino acids and astrocytes with behaviour disorder.
Isobe-Harima Y; Terai S; Miura I; Segawa M; Murata T; Itamoto K; Taura Y; Shinoda K; Sakaida I
Liver Int; 2008 Jan; 28(1):117-25. PubMed ID: 17971093
[TBL] [Abstract][Full Text] [Related]
9. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.
Harrison PM; Keays R; Bray GP; Alexander GJ; Williams R
Lancet; 1990 Jun; 335(8705):1572-3. PubMed ID: 1972496
[TBL] [Abstract][Full Text] [Related]
10. A surgical model of fulminant hepatic failure in rabbits.
Hung KC; Yong CC; Chen YS; Eng HL; Kuo FY; Lin CC; Young TH; Kobayashi E; Chen CL; Wang CC
Liver Int; 2007 Dec; 27(10):1333-41. PubMed ID: 18036098
[TBL] [Abstract][Full Text] [Related]
11. Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters.
Potter WZ; Thorgeirsson SS; Jollow DJ; Mitchell JR
Pharmacology; 1974; 12(3):129-43. PubMed ID: 4445191
[No Abstract] [Full Text] [Related]
12. Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
Slitt AM; Dominick PK; Roberts JC; Cohen SD
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):487-94. PubMed ID: 15910414
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure.
Schmidt LE; Larsen FS
Crit Care Med; 2006 Feb; 34(2):337-43. PubMed ID: 16424712
[TBL] [Abstract][Full Text] [Related]
14. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
Manning BW; Franklin MR; Galinsky RE
Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
[TBL] [Abstract][Full Text] [Related]
15. The effects of hepatic microsomal enzyme inducers on the pharmacokinetics of ouabain after portal and systemic administration to rats.
Thompson TN; Klaassen CD
J Pharm Pharmacol; 1995 Dec; 47(12A):1041-7. PubMed ID: 8932692
[TBL] [Abstract][Full Text] [Related]
16. A protective effect of glutathione-dextran macromolecular conjugates on acetaminophen-induced hepatotoxicity dependent on molecular size.
Kaneo Y; Ogawa K; Tanaka T; Fujihara Y; Iguchi S
Biol Pharm Bull; 1994 Oct; 17(10):1379-84. PubMed ID: 7533021
[TBL] [Abstract][Full Text] [Related]
17. A model of fulminant hepatic failure in the rabbit.
Blitzer BL; Waggoner JG; Jones EA; Gralnick HR; Towne D; Butler J; Weise V; Kopin IJ; Walters I; Teychenne PF; Goodman DG; Berk PD
Gastroenterology; 1978 Apr; 74(4):664-71. PubMed ID: 631503
[TBL] [Abstract][Full Text] [Related]
18. Reduction by acetylsalicylic acid of paracetamol-induced hepatic glutathione depletion in rats treated with 4,4'-dichlorobiphenyl, phenobarbitone and pregnenolone-16-alpha-carbonitrile.
van Bree L; Groot EJ; De Vries J
J Pharm Pharmacol; 1989 May; 41(5):343-5. PubMed ID: 2569524
[TBL] [Abstract][Full Text] [Related]
19. An improved model of acetaminophen-induced fulminant hepatic failure in dogs.
Kelly JH; Koussayer T; He DE; Chong MG; Shang TA; Whisennand HH; Sussman NL
Hepatology; 1992 Feb; 15(2):329-35. PubMed ID: 1735538
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Overexpression of Annexin A1 and A2 in Thioacetamide-Primed Mice Protects Them Against Acetaminophen-Induced Liver Failure and Death.
Dadhania VP; Muskhelishvili L; Latendresse JR; Mehendale HM
Int J Toxicol; 2016 Nov; 35(6):654-665. PubMed ID: 27451051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
